Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Metastatic Melanoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT03589339
What this trial is testing

NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy

Who this might be right for
RadiotherapyImmunotherapyMicrosatellite Instability-High Solid Malignant Tumour+8 more
Nanobiotix 145
Testing effectiveness (Phase 2)Study completedNCT00053781
What this trial is testing

Perifosine in Treating Patients With Metastatic or Recurrent Malignant Melanoma

Who this might be right for
Melanoma (Skin)
NCIC Clinical Trials Group 18
Testing effectiveness (Phase 2)Study completedNCT02275416
What this trial is testing

Safety of UV1 Vaccination in Combination With Ipilimumab in Patients With Unresectable or Metastatic Malignant Melanoma

Who this might be right for
Malignant Melanoma
Ultimovacs ASA 12
Large-scale testing (Phase 3)Looking for participantsNCT05727904
What this trial is testing

Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

Who this might be right for
Metastatic MelanomaUnresectable MelanomaMelanoma
Iovance Biotherapeutics, Inc. 670
Testing effectiveness (Phase 2)Study completedNCT00306514
What this trial is testing

Safety and Immunogenicity of a Melan-A VLP Vaccine in Advanced Stage Melanoma Patients

Who this might be right for
Melanoma
Cytos Biotechnology AG
Post-approval studies (Phase 4)UnknownNCT00226473
What this trial is testing

Standard Palliative Care Versus Standard Palliative Care Plus Polychemotherapy in Metastasized Malignant Melanoma

Who this might be right for
Metastatic Melanoma
Dermatologic Cooperative Oncology Group 200
Testing effectiveness (Phase 2)Looking for participantsNCT04511013
What this trial is testing

Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

Who this might be right for
Acral Lentiginous MelanomaClinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Cutaneous Melanoma+4 more
SWOG Cancer Research Network 112
Testing effectiveness (Phase 2)Active Not RecruitingNCT02650986
What this trial is testing

Gene-Modified T Cells With or Without Decitabine in Treating Patients With Advanced Malignancies Expressing NY-ESO-1

Who this might be right for
Advanced Fallopian Tube CarcinomaAdvanced Malignant Solid NeoplasmAdvanced Melanoma+47 more
Roswell Park Cancer Institute 15
Early research (Phase 1)WithdrawnNCT06626256
What this trial is testing

STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma

Who this might be right for
Locally Advanced Cervical CarcinomaLocally Advanced Colorectal CarcinomaLocally Advanced Malignant Solid Neoplasm+24 more
City of Hope Medical Center
Testing effectiveness (Phase 2)Study completedNCT00336986
What this trial is testing

Efficacy Study of IL-21 to Treat Metastatic Melanoma

Who this might be right for
CancerMalignant Melanoma
Novo Nordisk A/S 54
Testing effectiveness (Phase 2)Active Not RecruitingNCT05415072
What this trial is testing

A Phase I/II Study of DYP688 in Patients With Metastatic Uveal Melanoma and Other GNAQ/11 Mutant Melanomas

Who this might be right for
Metastatic Uveal Melanoma
Novartis Pharmaceuticals 66
Not applicableLooking for participantsNCT05053555
What this trial is testing

High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies

Who this might be right for
Liver Malignant TumorsCholangiocarcinoma MetastaticPancreatic Cancer+1 more
M.D. Anderson Cancer Center 60
Early research (Phase 1)Study completedNCT04430842
What this trial is testing

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S

Who this might be right for
AstrocytomaBrain CancerBrain Metastases+20 more
Quadriga Biosciences, Inc. 15
Testing effectiveness (Phase 2)Study completedNCT00003828
What this trial is testing

S9804: Vinorelbine in Treating Patients With Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
SWOG Cancer Research Network 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT02910700
What this trial is testing

Nivolumab With Trametinib and Dabrafenib, or Encorafenib and Binimetinib in Treating Patients With BRAF Mutated Metastatic or Unresectable Stage III-IV Melanoma

Who this might be right for
Metastatic Malignant Neoplasm in the BrainMetastatic MelanomaStage III Cutaneous Melanoma AJCC v7+5 more
M.D. Anderson Cancer Center 52
Early research (Phase 1)Ended earlyNCT06546553
What this trial is testing

Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines.

Who this might be right for
NeoplasmsNon-small-cell Lung CancerSquamous Cell Carcinoma of the Head and Neck+3 more
Pfizer 10
Early research (Phase 1)Study completedNCT01186601
What this trial is testing

Exploration of Tumor Accumulation of BAY94-9392 in Patients With Cancer

Who this might be right for
Neoplasms
Lantheus Biosciences Ltd. 30
Testing effectiveness (Phase 2)Study completedNCT02308553
What this trial is testing

Efficacy and Safety of Nintedanib Combined With Paclitaxel Chemotherapy for Patients With BRAF wt Metastatic Melanoma

Who this might be right for
Cutaneous Malignant Melanoma
Prof. Dr. med. Dirk Schadendorf 33
Testing effectiveness (Phase 2)Looking for participantsNCT06940739
What this trial is testing

Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel

Who this might be right for
Unresectable MelanomaMetastatic MelanomaOcular Melanoma
Iovance Biotherapeutics, Inc. 42
Early research (Phase 1)Study completedNCT02020707
What this trial is testing

Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers

Who this might be right for
Cervical AdenocarcinomaCervical AdenosarcomaCervical Adenosquamous Carcinoma+45 more
Mayo Clinic 43
Next Page